Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Outcomes of allogeneic hematopoietic stem cell transplantations (HSCT) for treatment of secondary primary malignancies arising post-autologous HSCT for multiple myeloma

Kyle Sugg, Hyejeong Jang, Seongho Kim, Jose Maciel Larios, Andrew Kin, Lois Ayash, Joseph Uberti, Dipenkumar Modi, Abhinav Deol

Blood (2025) 146 (Supplement 1): 7807.

https://doi.org/10.1182/blood-2025-7807

Published: 2025

Journal Articles

Effect of post-transplant cyclophosphamide on outcomes in stem cell transplant recipients with myelofibrosis

MacKenzie Mayo, Saumya Karne, Hyejeong Jang, Seongho Kim, Jose Maciel Larios, Dipenkumar Modi, Andrew Kin, Lois Ayash, Joseph Uberti, Abhinav Deol

Blood (2025) 146 (Supplement 1): 7832.

https://doi.org/10.1182/blood-2025-7832

Published: 2025

Journal Articles

Race does not impact chimeric antigen receptor T-cell therapy outcomes for multiple myeloma and diffuse large B cell lymphoma

Anisha Rajavel, Sushmitha Nanja Reddy, Saumya Karne, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Dipenkumar Modi, Andrew Kin, Joseph Uberti, Abhinav Deol

Blood (2025) 146 (Supplement 1): 6327.

https://doi.org/10.1182/blood-2025-6327

Published: 2025

Journal Articles

Outcomes of outpatient chimeric antigen receptor T-cell therapy administration: A single center experience at an urban hospital

Anisha Rajavel, Saumya Karne, Sushmitha Nanja Reddy, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Dipenkumar Modi, Andrew Kin, Joseph Uberti, Abhinav Deol

Blood (2025) 146 (Supplement 1): 6329.

https://doi.org/10.1182/blood-2025-6329

Published: 2025

Journal Articles

Race matters: Cytopenia trajectories after chimeric antigen receptor T- cell therapy in a single-center study

Sushmitha Nanja Reddy, Anisha Rajavel, Saumya Karne, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Andrew Kin, Lois Ayash, Joseph Uberti, Dipenkumar Modi, Abhinav Deol

Blood (2025) 146 (Supplement 1): 4170.

https://doi.org/10.1182/blood-2025-4170

Published: 2025

Journal Articles

Non-relapse mortality in patients who received CAR T-cell therapy at an urban hospital

Saumya Karne, Anisha Rajavel, Sushmitha Nanja Reddy, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Andrew Kin, Joseph Uberti, Dipenkumar Modi, Abhinav Deol

Blood (2025) 146 (Supplement 1): 4160.

https://doi.org/10.1182/blood-2025-4160

Published: 2025

Journal Articles

A Phase II Investigator-Initiated Trial of Epcoritamab with Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-Cell Lymphoma

Dipenkumar Modi, Seongho Kim, Mary Domagalski, Varun Mittal

Blood (2024) 144 (Supplement 1): 1742.4.

https://doi.org/10.1182/blood-2024-211276

Published: 2024

Journal Articles

A Decentralized Phase II Open-Label Trial Assessing the Safety and Efficacy of Dapagliflozin in Renal AL Amyloidosis (FLORAL)

Aditi Sharma, Joel Topf, Christiane A. Houde, Cathy Galasso, Sarah Phillips, Carmen Mitteer, Amanda Guido, Lori McFadden, Katelyn Staub, Amy Blake, Joseph Ellul, Andrew Kin, Craig Emmitt Cole, Abhinav Deol, Joseph Schiavi, Seongho Kim, Jeffrey A. Zonder

Blood (2024) 144 (Supplement 1): 1927.2.

https://doi.org/10.1182/blood-2024-211533

Published: 2024

Journal Articles

An Investigator Initiated Study of RCHOP in Combination with Selinexor (KPT-330) in Diffuse Large B Cell Lymphoma and Richter Transformation

Dipenkumar Modi, Jay Yang, Seongho Kim, Asfar Azmi, Emily Tolksdorf, Christiane A. Houde, Jeffrey A. Zonder

Blood (2024) 144 (Supplement 1): 3123.4.

https://doi.org/10.1182/blood-2024-209059

Published: 2024

Journal Articles

Trial in Progress: Iberdomide and Daratumumab As Maintenance Therapy after an Autologous Stem Cell Transplant for Multiple Myeloma (the IBEX Trial)

Andrew Kin, Jeffrey A. Zonder, Craig Emmitt Cole, Abhinav Deol, Suresh Kumar Balasubramanian, Seongho Kim, Christiane A. Houde, Joseph Ellul, Amy Blake, Katelyn Staub, Amanda Guido, Erik Carr, Sarah Phillips, Julie Boerner

Blood (2024) 144 (Supplement 1): 7007.

https://doi.org/10.1182/blood-2024-210562

Published: 2024

Journal Articles

Acute Leukemia and MDS Patients Older Than 70 Years Have Inferior Survival Following Allogeneic Stem Cell Transplant Compared to Those with 60-69 Years of Age

Asmita Shukla, Seongho Kim, Hyejeong Jang, Andrew Kin, Aasiya Matin, Lois Ayash, Abhinav Deol, Voravit Ratanatharathorn, Joseph Uberti, Dipenkumar Modi

Blood (2023) 142 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2023-190562

Published: 2023

Journal Articles

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Dipenkumar Modi, Maya Shatta, Seongho Kim, Abhinav Deol, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti

Blood (2022) 140 (Supplement 1): 694–695.

https://doi.org/10.1182/blood-2022-166536

Published: 2022

Journal Articles

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Malini Surapaneni, Samer Alkassis, Seongho Kim, Abhinav Deol, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph P. Uberti, Dipenkumar Modi

Blood (2021) 138 (Supplement 1): 4812.

https://doi.org/10.1182/blood-2021-148961

Published: 2021

Journal Articles

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Omar Albanyan, Hyejeong Jang, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, Abhinav Deol

Blood (2021) 138 (Supplement 1): 4879.

https://doi.org/10.1182/blood-2021-144995

Published: 2021

Journal Articles

A Systematic Review and Meta-Analysis Comparing Type I and II FLT3 Inhibitors in Relapsed/ Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Mai M M Aly, Mahesh Swaminathan, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2021) 138 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2021-148902

Published: 2021

Journal Articles

A Phase II Study Evaluating Safety and Efficacy of Polatuzumab Vedotin in Combination with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients with Previously Untreated Double and Triple Hit Lymphoma

Dipenkumar Modi, Seongho Kim, Silva Pregja, Christiane Houde, Kathy A. Reichel, Rod Ramchandren

Blood (2021) 138 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2021-149793

Published: 2021

Journal Articles

Efficacy Analysis of Different FLT3 Inhibitors in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients - a Systematic Review and Meta-Analysis

Mahesh Swaminathan, Mai M M Aly, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2021) 138 (Supplement 1): 1225.

https://doi.org/10.1182/blood-2021-154098

Published: 2021

Journal Articles

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Omar Albanyan, MD, Samer Alkassis, Seongho Kim, PhD, Andrew Kin, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Dipenkumar Modi, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-140079

Published: 2020

Journal Articles

Outcomes of Elderly cHL Patients in the Novel Agent Area: Improved Survival Since 2011 in the SEER-Registry Analysis

Harsh Shah, DO, Seongho Kim, PhD, Hyejeong Jang, Ahmad S Halwani, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-137228

Published: 2020

Journal Articles

Incidence, Risk Factors and Outcomes of Cardiac Toxicity in Haploidentical Peripheral Stem Cell Transplantation with High Dose Cyclophosphamide

Omar Albanyan, MD, Seongho Kim, PhD, Anupama Kottam, MD, Abhinav Deol, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Dipenkumar Modi, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-141416

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Outcomes of allogeneic hematopoietic stem cell transplantations (HSCT) for treatment of secondary primary malignancies arising post-autologous HSCT for multiple myeloma

Effect of post-transplant cyclophosphamide on outcomes in stem cell transplant recipients with myelofibrosis

Race does not impact chimeric antigen receptor T-cell therapy outcomes for multiple myeloma and diffuse large B cell lymphoma

Outcomes of outpatient chimeric antigen receptor T-cell therapy administration: A single center experience at an urban hospital

Race matters: Cytopenia trajectories after chimeric antigen receptor T- cell therapy in a single-center study

Non-relapse mortality in patients who received CAR T-cell therapy at an urban hospital

A Phase II Investigator-Initiated Trial of Epcoritamab with Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-Cell Lymphoma

A Decentralized Phase II Open-Label Trial Assessing the Safety and Efficacy of Dapagliflozin in Renal AL Amyloidosis (FLORAL)

An Investigator Initiated Study of RCHOP in Combination with Selinexor (KPT-330) in Diffuse Large B Cell Lymphoma and Richter Transformation

Trial in Progress: Iberdomide and Daratumumab As Maintenance Therapy after an Autologous Stem Cell Transplant for Multiple Myeloma (the IBEX Trial)

Acute Leukemia and MDS Patients Older Than 70 Years Have Inferior Survival Following Allogeneic Stem Cell Transplant Compared to Those with 60-69 Years of Age

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

A Systematic Review and Meta-Analysis Comparing Type I and II FLT3 Inhibitors in Relapsed/ Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

A Phase II Study Evaluating Safety and Efficacy of Polatuzumab Vedotin in Combination with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients with Previously Untreated Double and Triple Hit Lymphoma

Efficacy Analysis of Different FLT3 Inhibitors in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients - a Systematic Review and Meta-Analysis

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Outcomes of Elderly cHL Patients in the Novel Agent Area: Improved Survival Since 2011 in the SEER-Registry Analysis

Incidence, Risk Factors and Outcomes of Cardiac Toxicity in Haploidentical Peripheral Stem Cell Transplantation with High Dose Cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only